| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.4B | $4.7B | $5.0B | $5.9B | $6.4B | $1.7B | $1.4B | $1.4B |
| Cost of Revenue | $1.3B | $1.2B | $1.7B | $1.9B | $1.9B | $1.7B | $1.8B | $1.9B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B |
| SG&A Expense | $1.2B | $1.2B | $1.5B | $1.7B | $1.4B | $1.3B | $1.0B | $1.3B |
| Operating Income | $0.0B | $0.7B | $-1.5B | $0.4B | $0.8B | $0.2B | $0.2B | $0.0B |
| Net Income | $-0.3B | $0.4B | $-1.5B | $0.2B | $0.4B | $0.1B | $0.3B | $0.0B |
| EPS (Basic) | $-2.30 | $2.77 | $-10.73 | $1.47 | $3.11 | $0.77 | $2.02 | $0.07 |
| EPS (Diluted) | $-2.30 | $2.75 | $-10.73 | $1.46 | $3.10 | $0.76 | $2.01 | $0.07 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.6B | $6.3B | $6.5B | $9.3B | $10.0B | $10.8B | $8.9B | $5.3B |
| Current Assets | $2.6B | $2.2B | $2.3B | $3.0B | $3.7B | $3.8B | $6.7B | $3.1B |
| Cash & Equivalents | — | — | — | — | — | — | $4.6B | $1.2B |
| Total Liabilities | $5.0B | $5.2B | $5.5B | $6.4B | $7.0B | $7.9B | $5.9B | $3.5B |
| Current Liabilities | $1.9B | $1.4B | $2.1B | $2.2B | $2.5B | $2.4B | $1.3B | $1.3B |
| Stockholders' Equity | — | — | — | — | — | — | $3.0B | $1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.8B | $0.7B | $0.4B | $0.8B | $1.0B | $0.7B | $0.6B |
| Investing Cash Flow | $-0.3B | $-0.2B | $0.1B | $-0.3B | $0.2B | $-4.5B | $-0.1B | $-0.3B |
| Capital Expenditures | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.5B | $-0.5B | $-0.8B | $-0.6B | $-1.5B | $0.4B | $2.8B | $-0.7B |